Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Preferred Shares (2020 - 2021)

Treace Medical Concepts filings provide 2 years of Preferred Shares readings, the most recent being $7.9 million for Q1 2021.

  • On a quarterly basis, Preferred Shares changed N/A to $7.9 million in Q1 2021 year-over-year; TTM through Mar 2021 was $7.9 million, a N/A change, with the full-year FY2020 number at $7.9 million, changed N/A from a year prior.
  • Preferred Shares hit $7.9 million in Q1 2021 for Treace Medical Concepts, roughly flat from $7.9 million in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $7.9 million in Q4 2020 to a low of $7.9 million in Q4 2020.